Evidence map›Paper›PMID 41868659›Full record

ArticleAmerican journal of cancer research2026

Wei Wei, Jingyi Huang, Le Xie, Zhanping Xu, Canbin Lin, Ming Chen

Abstract read
In one paragraph

Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei WeiDepartment of Urology, Foshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine Foshan 528000, Guangdong, China.
Jingyi HuangKey Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University Guangzhou 510006, Guangdong, China.
Le XieDepartment of Pathology, Foshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine Foshan 528000, Guangdong, China.
Zhanping XuDepartment of Urology, Foshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine Foshan 528000, Guangdong, China.
Canbin LinDepartment of Urology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510405, Guangdong, China.
Ming ChenDepartment of Urology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510405, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Castration-resistant prostate cancer (CRPC) remains a major challenge due to limited treatment options and frequent therapeutic resistance. This study demonstrates that

Indexed as

Castration-resistant prostate cancerPGC-1αPhellinus linteus polysaccharidesPIK3R1

Identifiers

PMID41868659
PMCPMC13000144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.